HySum Flexibles Global 300501.SZ · CNY

Its shares trade on Shenzhen under the ticker 300501.SZ. It has been listed since 4 February 2016. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.10bn and a net loss of CN¥23.3m. At that date it held total assets of CN¥2.91bn and shareholders' equity of CN¥1.56bn.

Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. engages in the research, development, production, and sale of pharmaceutical packaging materials. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2016-02-04. The firm's major products include cold-forming composite hard sheet, polyterephthalate (PTP) aluminum foil and suppository (SP) films. Other products include polytrifluorochloroethylene (PTFCE) and polyvinyl chloride (PVC) composite hard sheet. Its products are widely used in the packaging of pharmaceutical, such as tablets, pills, capsules, granules, powders and suppositories, among others.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Wuhui LinChairman of the Board, General ManagerCN¥852,000
• Mr. Hailong NiChief Financial OfficerCN¥342,000
• Mr. Qin HuangChief Investment Officer, Deputy General Manager, Director, since 2019CN¥342,000
• Mr. Ping ChenDeputy General ManagerCN¥700,000
• Mr. Jun LiDeputy General ManagerCN¥870,000
• Mr. Gaofeng YangSecretary of the BoardCN¥408,000
• Mr. Xin LinDirectorCN¥260,900
• Ms. Xiumei ZhuDirectorCN¥342,000
• Mr. Xun GuoIndependent Director
• Mr. Shihong MaIndependent DirectorCN¥60,000
• Ms. Linlin WangIndependent DirectorCN¥10,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.